60
Quince Therapeutics, Inc. raises $114.7M under Reg D
Company raise · Raising · Offering $186.4M · Sold $114.7M · SOUTH SAN FRANCISCO, CA · filed 2026-06-11
Placement agent engaged
45
Quince Therapeutics, Inc. raises $7.4M under Reg D
Company raise · Pre-first close · SOUTH SAN FRANCISCO, CA · Form D filed 2026-06-11
Placement agent engagedBusiness combination
Why now — by persona
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
People on the filing
| David Lamond | Director |
| Christopher Senner | Director |
| Charles Ryan | Executive Officer |
| Brendan Hannah | Executive Officer |
| Dirk Thye | Executive Officer, Director |
| Brigette Roberts | Executive Officer, Director |
| June Bray | Director |
Signed by Dirk Thye, Chief Executive Officer.
Placement agents / sales compensation: LifeSci Capital
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.
Other filings by this issuer
57
Quince Therapeutics, Inc. raises $11.5M under Reg D
Company raise · Raising · Offering $21.9M · Sold $11.5M · SOUTH SAN FRANCISCO, CA · filed 2025-07-01
Placement agent engaged